StonvexLoading…
StonvexStonvexStonvexCore line items from INCY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.14B | $4.24B | $3.70B | $3.39B |
Operating Income | $1.51B | $61.37M | $620.52M | $579.44M |
Net Income | $1.29B | $32.62M | $597.60M | $340.66M |
EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 |
Total Assets | $6.96B | $5.44B | $6.78B | $5.84B |
Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B |
Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $892.11M |
Shares Outstanding | 198.46M | 193.43M | 224.29M | 222.75M |